✦ LIBER ✦

Reduced risk of hepatocellular carcinoma after interferon therapy in aged patients with chronic hepatitis C is limited to sustained virological responders

✍ Scribed by Y. Imai; S. Tamura; H. Tanaka; N. Hiramatsu; S. Kiso; Y. Doi; M. Inada; T. Nagase; T. Kitada; K. Imanaka; K. Fukuda; T. Takehara; A. Kasahara; N. Hayashi

Book ID: 108886314
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 157 KB
Volume: 17
Category: Article
ISSN: 1352-0504
DOI: 10.1111/j.1365-2893.2009.01163.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk factors for development of hepatoce

Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon

✍ Masafumi Ikeda; Shigetoshi Fujiyama; Motohiko Tanaka; Michio Sata; Tatsuya Ide; 📂 Article 📅 2005 🏛 Springer Japan 🌐 English ⚖ 185 KB

Risk factors for the development of hepa

Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapy

✍ HAJIME TOKITA; HIDEO FUKUI; AKIHISA TANAKA; HIROSHI KAMITSUKASA; MICHIYASU YAGUR 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

Meta-analysis: Reduced incidence of hepa

Meta-analysis: Reduced incidence of hepatocellular carcinoma in patients not responding to interferon therapy of chronic hepatitis C

✍ Yasuhiro Miyake; Yoshiaki Iwasaki; Kazuhide Yamamoto 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 252 KB 👁 1 views

## Abstract Interferon treatment for chronic hepatitis C reduces the incidence of hepatocellular carcinoma (HCC) in sustained responders. However, estimation of the effect of interferon treatment on HCC development in nonresponders is yet to be fully implemented. We conducted a meta‐analysis of 3 r

Characteristics of patients with chronic

Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy

✍ Akiko Makiyama; Yoshito Itoh; Akinori Kasahara; Yasuharu Imai; Sumio Kawata; Ken 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 3 views

## Abstract ## BACKGROUND The objective of the current study was to determine the characteristic features of sustained responders who develop hepatocellular carcinoma after treatment with interferon for chronic hepatitis C. ## METHODS This study included 3626 patients with chronic hepatitis C wh

Characteristics of patients with chronic

Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy

✍ Monica Basso; Francesco Torre; Antonino Picciotto 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB 👁 3 views

Varying incidence of cirrhosis and hepat

Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy

✍ Michiko Shindo; Arai Ken; Tadao Okuno 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 3 views

## BACKGROUND. To determine whether interferon (IFN) therapy can reduce incidence of the development of cirrhosis and hepatocellular carcinoma equally in patients with chronic hepatitis C virus (HCV) who responded differently to therapy, a retrospective analysis of 250 patients treated with IFN wa